» Articles » PMID: 21124777

The Chaperone-dependent Ubiquitin Ligase CHIP Targets HIF-1α for Degradation in the Presence of Methylglyoxal

Overview
Journal PLoS One
Date 2010 Dec 3
PMID 21124777
Citations 67
Authors
Affiliations
Soon will be listed here.
Abstract

Hypoxia-inducible factor-1 (HIF-1) plays a key role in cell adaptation to low oxygen and stabilization of HIF-1 is vital to ensure cell survival under hypoxia. Diabetes has been associated with impairment of the cell response to hypoxia and downregulation of HIF-1 is most likely the event that transduces hyperglycemia into increased cell death in diabetes-associated hypoxia. In this study, we aimed at identifying the molecular mechanism implicated in destabilization of HIF-1 by high glucose. In this work, we identified a new molecular mechanism whereby methylglyoxal (MGO), which accumulates in high-glucose conditions, led to a rapid proteasome-dependent degradation of HIF-1α under hypoxia. Significantly, MGO-induced degradation of HIF-1α did not require the recruitment of the ubiquitin ligase pVHL nor did it require hydroxylation of the proline residues P402/P564 of HIF-1α. Moreover, we identified CHIP (Carboxy terminus of Hsp70-Interacting Protein) as the E3 ligase that ubiquitinated HIF-1α in the presence of MGO. Consistently, silencing of endogenous CHIP and overexpression of glyoxalase I both stabilized HIF-1α under hypoxia in the presence of MGO. Data shows that increased association of Hsp40/70 with HIF-1α led to recruitment of CHIP, which promoted polyubiquitination and degradation of HIF-1α. Moreover, MGO-induced destabilization of HIF-1α led to a dramatic decrease in HIF-1 transcriptional activity. Altogether, data is consistent with a new pathway for degradation of HIF-1α in response to intracellular accumulation of MGO. Moreover, we suggest that accumulation of MGO is likely to be the link between high glucose and the loss of cell response to hypoxia in diabetes.

Citing Articles

Network pharmacology-based study on the mechanism of Tangfukang formula against type 2 diabetes mellitus.

Kai Y, Wei W, Yan W, Huijuan G, Xingzhong F J Tradit Chin Med. 2025; 45(1):76-88.

PMID: 39957161 PMC: 11764938. DOI: 10.19852/j.cnki.jtcm.2025.01.007.


β-Cell Deletion of Hypoxia-Inducible Factor 1α (HIF-1α) Increases Pancreatic β-Cell Susceptibility to Streptozotocin.

Yu J, Lalwani A, Gunton J Int J Mol Sci. 2025; 25(24.

PMID: 39769216 PMC: 11676740. DOI: 10.3390/ijms252413451.


Nanoscale Systems for Local Activation of Hypoxia-Inducible Factor-1 Alpha: A New Approach in Diabetic Wound Management.

Saber S, Abdelhady R, Elhemely M, Elmorsy E, Hamad R, Abdel-Reheim M Int J Nanomedicine. 2024; 19:13735-13762.

PMID: 39723173 PMC: 11669355. DOI: 10.2147/IJN.S497041.


The Use of Dissolvable Synthetic Calcium Impregnated with Antibiotic in Osteoarticular Infection in Patients with Diabetes.

Cursaru A, Cursaru R, Iordache S, Costache M, Cretu B, Serban B Life (Basel). 2024; 14(10).

PMID: 39459635 PMC: 11509661. DOI: 10.3390/life14101335.


Targeting hypoxia and thrombospondin-2 in diabetic wound healing.

Huang Y, Xing H, Naud S, Kyriakides T FASEB J. 2024; 38(19):e70091.

PMID: 39383062 PMC: 11486302. DOI: 10.1096/fj.202302429RRR.


References
1.
Ravi R, Mookerjee B, Bhujwalla Z, Sutter C, Artemov D, Zeng Q . Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha. Genes Dev. 2000; 14(1):34-44. PMC: 316350. View

2.
Hansson L, Friedler A, Freund S, Rudiger S, Fersht A . Two sequence motifs from HIF-1alpha bind to the DNA-binding site of p53. Proc Natl Acad Sci U S A. 2002; 99(16):10305-9. PMC: 124909. DOI: 10.1073/pnas.122347199. View

3.
Yu D, Cringle S . Retinal degeneration and local oxygen metabolism. Exp Eye Res. 2005; 80(6):745-51. DOI: 10.1016/j.exer.2005.01.018. View

4.
Xu W, Marcu M, Yuan X, Mimnaugh E, Patterson C, Neckers L . Chaperone-dependent E3 ubiquitin ligase CHIP mediates a degradative pathway for c-ErbB2/Neu. Proc Natl Acad Sci U S A. 2002; 99(20):12847-52. PMC: 130548. DOI: 10.1073/pnas.202365899. View

5.
Thornalley P . Protein and nucleotide damage by glyoxal and methylglyoxal in physiological systems--role in ageing and disease. Drug Metabol Drug Interact. 2008; 23(1-2):125-50. PMC: 2649415. DOI: 10.1515/dmdi.2008.23.1-2.125. View